- Charles River Laboratories ( NYSE: CRL ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open.
- The consensus EPS Estimate is $2.74 (+5.0% Y/Y) and the consensus Revenue Estimate is $995.12M (+8.8% Y/Y).
- Over the last 2 years, CRL has beaten EPS estimates 100% of the time and has beaten revenue estimates 88% of the time.
- Over the last 3 months, EPS estimates have seen 1 upward revision and 11 downward. Revenue estimates have seen 1 upward revision and 9 downward.
For further details see:
Charles River Laboratories Q2 2022 Earnings Preview